Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin

M. Babich, S. R. Hamann, R. G. McAllister, C. Pratap Reddy, M. T. Piascik

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Although coadministration of verapamil and digoxin results in significant increases in plasma glycoside concentrations, evidence of digitalis toxicity appears to be infrequent with this combination. To evaluate the effect of verapamil on electrophysioloic toxicity from digitalis, 5 anesthetized dogs were instrumented for physiologic recording and given acetylstrophanthidin by intravenous infusion until evidence of toxicity appeared. Each animal was then treated with verapamil intravenously, with mean steady-state plasma levels of 177 ± 30 ng/ml, and acetylstrophanthidin infusion repeated; after return of sinus rhythm, the verapamil infusion was increased (producing mean levels of 379 ± 50 ng/ml) and acetylstrophanthidin given a third time. Prior to verapamil dosing, ventricular ectopy was the manifestation of glycoside toxicity; following the first verapamil infusion, only 20% of the dogs developed ectopy, the remainder having second- or third-degree atrioventricular (AV) block, or AV junctional tachycardia. With the higher verapamil dose, AV block or junctional tachycardia occurred in all animals during acetylstrophanthidin infusion. In addition, the dose of glycoside required to produce electrophysiologic toxicity was significantly increased by verapamil. Therefore, verapamil appears to exert a protective effect against the development of digitalis-induced arrhythmia, possibly by suppressing delayed afterpotential generation, and significantly increases the dose of digitalis required to produce AV block.

Original languageEnglish (US)
Pages (from-to)224-232
Number of pages9
JournalPharmacology
Volume29
Issue number4
StatePublished - 1984
Externally publishedYes

Fingerprint

Verapamil
Digitalis
Atrioventricular Block
Glycosides
Tachycardia
Dogs
acetylstrophanthidin
Digoxin
Intravenous Infusions
Cardiac Arrhythmias

ASJC Scopus subject areas

  • Pharmacology

Cite this

Babich, M., Hamann, S. R., McAllister, R. G., Pratap Reddy, C., & Piascik, M. T. (1984). Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin. Pharmacology, 29(4), 224-232.

Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin. / Babich, M.; Hamann, S. R.; McAllister, R. G.; Pratap Reddy, C.; Piascik, M. T.

In: Pharmacology, Vol. 29, No. 4, 1984, p. 224-232.

Research output: Contribution to journalArticle

Babich, M, Hamann, SR, McAllister, RG, Pratap Reddy, C & Piascik, MT 1984, 'Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin', Pharmacology, vol. 29, no. 4, pp. 224-232.
Babich M, Hamann SR, McAllister RG, Pratap Reddy C, Piascik MT. Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin. Pharmacology. 1984;29(4):224-232.
Babich, M. ; Hamann, S. R. ; McAllister, R. G. ; Pratap Reddy, C. ; Piascik, M. T. / Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin. In: Pharmacology. 1984 ; Vol. 29, No. 4. pp. 224-232.
@article{d37b1066de9040afa8dd6f036e074350,
title = "Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin",
abstract = "Although coadministration of verapamil and digoxin results in significant increases in plasma glycoside concentrations, evidence of digitalis toxicity appears to be infrequent with this combination. To evaluate the effect of verapamil on electrophysioloic toxicity from digitalis, 5 anesthetized dogs were instrumented for physiologic recording and given acetylstrophanthidin by intravenous infusion until evidence of toxicity appeared. Each animal was then treated with verapamil intravenously, with mean steady-state plasma levels of 177 ± 30 ng/ml, and acetylstrophanthidin infusion repeated; after return of sinus rhythm, the verapamil infusion was increased (producing mean levels of 379 ± 50 ng/ml) and acetylstrophanthidin given a third time. Prior to verapamil dosing, ventricular ectopy was the manifestation of glycoside toxicity; following the first verapamil infusion, only 20{\%} of the dogs developed ectopy, the remainder having second- or third-degree atrioventricular (AV) block, or AV junctional tachycardia. With the higher verapamil dose, AV block or junctional tachycardia occurred in all animals during acetylstrophanthidin infusion. In addition, the dose of glycoside required to produce electrophysiologic toxicity was significantly increased by verapamil. Therefore, verapamil appears to exert a protective effect against the development of digitalis-induced arrhythmia, possibly by suppressing delayed afterpotential generation, and significantly increases the dose of digitalis required to produce AV block.",
author = "M. Babich and Hamann, {S. R.} and McAllister, {R. G.} and {Pratap Reddy}, C. and Piascik, {M. T.}",
year = "1984",
language = "English (US)",
volume = "29",
pages = "224--232",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin

AU - Babich, M.

AU - Hamann, S. R.

AU - McAllister, R. G.

AU - Pratap Reddy, C.

AU - Piascik, M. T.

PY - 1984

Y1 - 1984

N2 - Although coadministration of verapamil and digoxin results in significant increases in plasma glycoside concentrations, evidence of digitalis toxicity appears to be infrequent with this combination. To evaluate the effect of verapamil on electrophysioloic toxicity from digitalis, 5 anesthetized dogs were instrumented for physiologic recording and given acetylstrophanthidin by intravenous infusion until evidence of toxicity appeared. Each animal was then treated with verapamil intravenously, with mean steady-state plasma levels of 177 ± 30 ng/ml, and acetylstrophanthidin infusion repeated; after return of sinus rhythm, the verapamil infusion was increased (producing mean levels of 379 ± 50 ng/ml) and acetylstrophanthidin given a third time. Prior to verapamil dosing, ventricular ectopy was the manifestation of glycoside toxicity; following the first verapamil infusion, only 20% of the dogs developed ectopy, the remainder having second- or third-degree atrioventricular (AV) block, or AV junctional tachycardia. With the higher verapamil dose, AV block or junctional tachycardia occurred in all animals during acetylstrophanthidin infusion. In addition, the dose of glycoside required to produce electrophysiologic toxicity was significantly increased by verapamil. Therefore, verapamil appears to exert a protective effect against the development of digitalis-induced arrhythmia, possibly by suppressing delayed afterpotential generation, and significantly increases the dose of digitalis required to produce AV block.

AB - Although coadministration of verapamil and digoxin results in significant increases in plasma glycoside concentrations, evidence of digitalis toxicity appears to be infrequent with this combination. To evaluate the effect of verapamil on electrophysioloic toxicity from digitalis, 5 anesthetized dogs were instrumented for physiologic recording and given acetylstrophanthidin by intravenous infusion until evidence of toxicity appeared. Each animal was then treated with verapamil intravenously, with mean steady-state plasma levels of 177 ± 30 ng/ml, and acetylstrophanthidin infusion repeated; after return of sinus rhythm, the verapamil infusion was increased (producing mean levels of 379 ± 50 ng/ml) and acetylstrophanthidin given a third time. Prior to verapamil dosing, ventricular ectopy was the manifestation of glycoside toxicity; following the first verapamil infusion, only 20% of the dogs developed ectopy, the remainder having second- or third-degree atrioventricular (AV) block, or AV junctional tachycardia. With the higher verapamil dose, AV block or junctional tachycardia occurred in all animals during acetylstrophanthidin infusion. In addition, the dose of glycoside required to produce electrophysiologic toxicity was significantly increased by verapamil. Therefore, verapamil appears to exert a protective effect against the development of digitalis-induced arrhythmia, possibly by suppressing delayed afterpotential generation, and significantly increases the dose of digitalis required to produce AV block.

UR - http://www.scopus.com/inward/record.url?scp=0021179629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021179629&partnerID=8YFLogxK

M3 - Article

C2 - 6494234

AN - SCOPUS:0021179629

VL - 29

SP - 224

EP - 232

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 4

ER -